Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies by Hiller, Thomas et al.
 International Journal of 
Molecular Sciences
Article
Generation of a 3D Liver Model Comprising Human
Extracellular Matrix in an Alginate/Gelatin-Based
Bioink by Extrusion Bioprinting for Infection and
Transduction Studies
Thomas Hiller 1,†, Johanna Berg 1,†, Laura Elomaa 2, Viola Röhrs 1, Imran Ullah 3, Katrin Schaar 1,
Ann-Christin Dietrich 1, Munir A. Al-Zeer 1, Andreas Kurtz 3, Andreas C. Hocke 4,
Stefan Hippenstiel 4, Henry Fechner 1, Marie Weinhart 2 and Jens Kurreck 1,*
1 Institute of Biotechnology, Department of Applied Biochemistry, Technische Universität Berlin,
13355 Berlin, Germany; thomas.hiller@tu-berlin.de (T.H.); johanna.berg@tu-berlin.de (J.B.);
viola.roehrs@tu-berlin.de (V.R.); katrin.schaar86@gmail.com (K.S.); a.dietrich@tu-berlin.de (A.-C.D.);
al-zeer@tu-berlin.de (M.A.A.-Z.); henry.fechner@tu-berlin.de (H.F.)
2 Institute of Chemistry and Biochemistry, Department of Organic Chemistry, Freie Universität Berlin,
14195 Berlin, Germany; laura.elomaa@fu-berlin.de (L.E.); marie.weinhart@fu-berlin.de (M.W.)
3 Berlin-Brandenburger Centrum für Regenerative Therapien, Charité - Universitätsmedizin Berlin,
13353 Berlin, Germany; imran.ullah@charite.de (I.U.); Andreas.Kurtz@charite.de (A.K.)
4 Dept. of Internal Medicine/Infectious and Respiratory Diseases, Charité − Universitätsmedizin Berlin,
10117 Berlin, Germany; andreas.hocke@charite.de (A.C.H.); Stefan.Hippenstiel@charite.de (S.H.)
* Correspondence: jens.kurreck@tu-berlin.de; Tel.: +49-30-314-27-582
† These authors contributed equally to this work.
Received: 23 August 2018; Accepted: 5 October 2018; Published: 12 October 2018


Abstract: Bioprinting is a novel technology that may help to overcome limitations associated
with two-dimensional (2D) cell cultures and animal experiments, as it allows the production of
three-dimensional (3D) tissue models composed of human cells. The present study describes the
optimization of a bioink composed of alginate, gelatin and human extracellular matrix (hECM) to
print human HepaRG liver cells with a pneumatic extrusion printer. The resulting tissue model
was tested for its suitability for the study of transduction by an adeno-associated virus (AAV)
vector and infection with human adenovirus 5 (hAdV5). We found supplementation of the basic
alginate/gelatin bioink with 0.5 and 1 mg/mL hECM provides desirable properties for the printing
process, the stability of the printed constructs, and the viability and metabolic functions of the
printed HepaRG cells. The tissue models were efficiently transduced by AAV vectors of serotype
6, which successfully silenced an endogenous target (cyclophilin B) by means of RNA interference.
Furthermore, the printed 3D model supported efficient adenoviral replication making it suitable to
study virus biology and develop new antiviral compounds. We consider the approach described
here paradigmatic for the development of 3D tissue models for studies including viral vectors and
infectious viruses.
Keywords: adeno-associated virus; adenovirus; bioprinting; infection; transduction; extracellular
matrix; liver; organ models; HepaRG; gene silencing
1. Introduction
Three-dimensional (3D) bioprinting enables the fabrication of cell-laden biological 3D structures,
which can contain multiple cell types as well as different biomaterials within a complex 3D geometry.
Printed 3D constructs may provide suitable systems to study gene therapeutic strategies as well
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as tissue-specific infection of different pathogens. As they can be generated with human cells,
they may reflect physiological conditions of humans better than animal experiments and thereby
help to overcome shortcomings of current models. For instance, for a number of human pathogens,
no appropriate animal model exists, as there are no natural hosts besides humans. In these cases,
repeated passaging may succeed in adapting the pathogens to replicate in animal models; however,
even when successful replication of the virus is achieved, the relevance of these models is often
restricted and the pathophysiological manifestation of the infection is limited compared to their
human equivalents [1–3]. For example, human adenovirus (AdV) does not replicate in mice
and requires an elaborate model, e.g., with immunosuppressed Syrian hamsters, to study their
biology [4]. AdV is a double-stranded DNA virus that usually causes mild, self-limiting infections
of the upper respiratory tract and the gastrointestinal tract as well as epidemic conjunctivitis [5].
However, in immunocompromised patients following organ transplantation, AdV can cause severe
infection with a fatal outcome [6]. Therapeutic options to treat severe courses of infection are limited,
indicating the need to further study AdV biology and develop new antiviral agents.
Another important topic in current biomedical research is the development of efficient
gene-delivery vehicles. Adeno-associated virus (AAV) vectors are among the most promising
candidates for gene therapeutic applications [7] and have already been approved for clinical use [8,9].
Still, their toxicity and tropism of the different serotypes in human tissues needs to be characterized in
more detail [10].
To overcome limits of currently established animal models, multicellular spheroids have
been considered as in vitro 3D culture microscale tissue analogs; however, they could not be
efficiently transduced with gene vectors [11,12]. Thus, 3D bioprinting offers an attractive alternative.
Stereolithography printers generate models with high precision [13]. However, they require potentially
harmful photo-inducible crosslinkers. Therefore, we chose an extrusion-based technology which
allows biocompatible printing of various polymers such as collagen, gelatin, alginate, chitosan,
silk or hyaluronic acid within a broad range of viscosities [14,15]. In particular, mixtures of alginate
and gelatin combine the thermo-sensitive properties of gelatin [16–18] with the Ca2+-dependent
cross-linking capabilities of alginate [19], thus providing properties well-suited for extrusion
printing. Though these inks offer good printability, they lack desirable biochemical and physiological
components. The addition of single extracellular matrix (ECM) components like collagen or laminin is
a widely used strategy intended to get around this limitation, but they lack the diversity of natural
ECM with respect to physical and biological complexity [20–22].
Thus, more complex human ECM (hECM) mimics like Matrigel™, which comprises a
basement membrane protein composition similar to that found in human ECM [23,24], have been
introduced for bioink optimization. However, Matrigel™, is extracted from a mouse tumor,
the Engelbreth–Holm–Swarm sarcoma [25,26], which gives rise to ethical concerns. As a result,
human ECM from decellularized human tissues is coming into focus for bioink optimization, since it
provides a complex environment of essential human biomolecules. Despite its promising physiological
properties, the application of ECM in 3D bioprinting approaches is difficult due to poor mechanical and
viscoelastic properties [21,27] so that the composition of bioinks containing ECM needs to be optimized.
In addition to the bioink, the cells used in a bioprinting setup are of utmost importance.
While primary cells, e.g., primary human hepatocytes (PHH) for a liver model, are the ultimate
source of choice, their availability is limited and they are often highly susceptible to mechanical
strain such as the shear stress during the printing process. Of all the currently available cell lines,
the HepaRG cell line is the most appropriate alternative to PHH [28], since it shows comparable
metabolic and morphologic properties. As a result, they are frequently applied for metabolic or cell
biology studies [29–31].
The present study aims at optimizing conditions using human decellularized ECM as a component
of an alginate/gelatin-based bioink, which can be used for extrusion-based bioprinting of a liver model
for transduction and infection studies. Such a bioink must fulfil the requirements of printability,
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structural integrity (shape fidelity), and cell viability. Furthermore, it must support transduction
by viral vectors and replication of infectious viruses. The hECM containing 3D constructs were
generated using a 3D micro extrusion bioprinter. Initially, printing conditions, viability/cytotoxicity,
and rheological properties were evaluated. In addition, the expression of metabolic markers over the
course of the experiments was quantified. Transduction of the constructs with AAV vectors of serotype
6 was found to lead to efficient RNA interference (RNAi)-mediated silencing of the endogenous target
human cyclophilin B (hCycB). Furthermore, the 3D constructs allowed proper replication of the human
adenovirus 5 demonstrating their suitability for study of the virus.
2. Results and Discussion
2.1. Preparation and Characterization of HepaRG Cell-Laden Hydrogels Containing Varying Amounts of
Extracellular Matrix (ECM)
The first aim of our study was to identify the optimal composition of a bioink to maintain
HepaRG cultivation in a printed 3D construct. Although being of non-human origin, the suitability of
alginate [19] and gelatin [16–18,32] for the fabrication of 3D scaffolds and bioprinting has been well
established [33,34]. Our previous results for the 3D printing of lung epithelial cells showed favorable
characteristics of blends containing alginate and gelatin in terms of printability, cell viability and
preservation of the shape of the generated constructs during culture [35]. Therefore, the same basic
bioink formulation consisting of 2% (w/v) alginate and 3% (w/v) gelatin was used to print mature
HepaRG cells. This basic bioink was supplemented with varying amounts of human ECM. In the
present study, we used lung-derived hECM for practical reasons. No substantial differences were
reported for the composition of lung and liver ECM [36,37]. Therefore, we carried out this proof of
concept study using lung-derived hECM in order to determine suitable hECM concentrations for
extrusion-based bioprinting of HepaRG-laden hydrogels. Concentrations of 0, 0.25, 0.5, 1 and 2 mg/mL
of decellularized hECM were added to the alginate/gelatin blend to determine the concentrations
which are most beneficial in terms of improving biocompatibility and attachment of the cells to the
matrix. The bioink contained 7 × 106 mature HepaRG cells/mL, so that each construct should contain
slightly less than 1 × 106 HepaRG cells. In fact, when we lysed the constructs and counted the cells by
trypan blue staining as previously described [35], we recovered approximately 750,000 cells from a
model. We used a rectangular construct (length 1 cm × width 1 cm × height 0.1 cm) with regularly
spaced pores laid out in a grid pattern for the experiments (Figure 1).
The bioinks used in the present study were of good printability and the shape of the constructs
was highly reproducible (Supplementary Figure S1). Furthermore, the 3D models were stable during
the cultivation time of seven days.
The spatial distribution of the mature HepaRG cells in the 3D printed constructs was analyzed
by fluorescence microscopy. To visualize the cells, nuclei were stained with Hoechst stain and the 3D
distribution was recorded with the Z-stack tool, which creates a projection of the transmitted light,
following one and seven days in culture. Although this method is of limited resolution, it provides an
overview over the cell distribution in the 3D printed construct. One day after printing, the HepaRG
cells were well distributed throughout the printed constructs, with no obvious differences between the
tested ECM concentrations (Figure 2A, upper row). At day seven after printing, the spatial distribution
of the HepaRG cells was less homogenous and the cells tended to sediment in all constructs (Figure 2A,
lower row); however, the bioink containing 1 mg/mL hECM was superior in maintaining spatial
distribution of the cells compared to the other concentrations tested. Sections from the top, middle and
bottom of the Z-stacks are shown in the Supplementary Figure S2.
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Figure 1. Experimental design of bioprinting and processing of cell-laden hybrid alginate/gelatin/ 
human extracellular matrix (hECM) constructs. Schematic workflow of the 3D printing procedure. 
Bioink components and living mature HepaRG cells were thoroughly mixed with two syringes 
connected by a Luer-Lock-adapter. Following initial Ca2+-driven cross-linking, the hydrogel was 
transferred into the dispensing cartridge in the print head and pneumatically extruded onto a dry and 
sterile petri dish. The thermal gelation of gelatin maintained the 3D structure of the construct during 
the printing process. Alginate was completely cross-linked by submersion in a CaCl2 solution. During 
incubation at 37 °C, the gelatin dissolves, while the hECM gelation takes over support of the structural 
stability. Experiments were performed one, three and seven days after printing. * Detailed explanation of 
the function which the components of the bioink have. 
Next, cell viability was qualitatively evaluated by staining living (calcein-AM, green) and dead 
(ethidium homodimer-1, red) cells after one and seven days of culture, followed by microscopic 
analysis. As obvious in Figure 2B (upper row), after one day of culture, cell viability was high in all 
bioink conditions except for 2 mg/mL hECM. This concentration resulted in a greater number of 
ethidium homodimer-1 positive, i.e., dead, cells compared to the other hECM concentrations. After 
seven days in culture (Figure 2B, lower row), the number of dead cells increased only slightly under 
all tested hECM conditions. Again, like after one day, the addition of 2 mg/mL hECM was detrimental 
as the percentage of dead cells was comparatively high. For constructs printed with bioinks 
containing 0.5 or 1 mg/mL hECM, the fraction of dead cells was also slightly lower than for those 
containing less hECM. While no differences in the number of calcein-AM positive, i.e., living, cells 
were detected after one day, seven days of culture with no or only 0.25 mg/mL hECM resulted in 
slightly reduced numbers of living HepaRG cells compared to 0.5 and 1 mg/mL hECM. Therefore, 
we concluded that hECM concentrations greater than 0.25 mg/mL and less than 2 mg/mL are best 
suited for cell viability. 
The metabolic activity of the bioprinted mature HepaRG cells was determined by quantification 
of the reduction of the tetrazolium salt XTT by dehydrogenase enzymes after one and seven days in 
culture (Figure 2C). Consistent with the results from the microscopic evaluation of the cell staining, 
measurement of the metabolic activity of the bioprinted HepaRG revealed that 2 mg/mL hECM are 
unfavorable for cultivation of HepaRG cells, resulting in reduced metabolic activity levels. Even 
though slight differences regarding the enzymatic activity between the different hECM concentrations 
Figure 1. Experimental design of bioprinting and processing of cell-laden hybrid alginate/gelatin human
extracellular m trix (hECM) constru ts. Schematic workflow of e 3D pr ting proc dure.
Bioink comp nents and living mature HepaRG cel re thoroughly mixed wi h two syringes
connected by a Luer-Lock-adapter. Following initial a -driven cross-linking, t e hydrogel was
transferred into the dispensing cartridge in the print head and pneumatically extruded onto a dry and
sterile petri dish. The thermal gelation of gelatin maintained the 3D structure of the construct during
the printing process. Alginate was completely cross-linked by submersion in a CaCl2 solution. During
incubation at 37 ◦C, the gelatin dissolves, while the hECM gelation takes over support of the structural
stability. Experiments were performed one, three and seven days after printing. * Detailed explanation
of the function which the components of the bioink have.
Next, cell viability was qualitatively evaluated by staining living (calcein-AM, green) and dead
(ethidium homodimer-1, red) cells after one and seven days of culture, followed by microscopic
analys s. As bviou in Figure B (upper row), after on day f culture, cell viability was high in
all bioink conditions except for 2 mg/mL hECM. This concentra ion resulted in a greater number
of ethidium homodimer-1 positive, i.e., dead, cells compared to the other hECM concentrations.
After seven days in culture (Figure 2B, lower row), the number of dead cells increased only slightly
under all tested hECM conditions. Again, like after one day, the addition of 2 mg/mL hECM was
detrimental as the percentage of dead cells was comparatively high. For constructs printed with
bioinks containing 0.5 or 1 mg/mL hECM, the fraction of dead cells was also slightly lower than
for those containing less hECM. While no differences in the number of calcein-AM positive, i.e.,
living, cells wer detected after one day, seven days of culture with no or only 0.25 g/mL hECM
resulted in slight y reduced numbers of living HepaRG cells compared to 0.5 and 1 mg/mL hECM.
Therefore, w concluded that hECM c ncentrations greater than 0.25 mg/mL and less than 2 mg/mL
are best suited for cell viability.
The metabolic activity of the bioprinted mature HepaRG cells was determined by quantification
of the reduction of the tetrazolium salt XTT by dehydrogenase enzymes after one and seven days in
culture (Figure 2C). Consistent with the results from the microscopic evaluation of the cell staining,
measurement of the metabolic activity of the bioprinted HepaRG revealed that 2 mg/mL hECM are
unfavorable for cultivation of HepaRG cells, resulting in reduced metabolic activity levels. Even though
slight differences regarding the enzymatic activity between the different hECM concentrations could
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be measured on days one and seven of culture, no significant decreases between day one and seven
were detected at a given concentration of hECM.
The two-dimensional (2D) cultured mature HepaRG monolayer, which contained a comparable
number of cells as the printed constructs, showed a significantly higher metabolic activity at day
one (Figure 2C). However, metabolic activity in the monolayer culture decreased over time and was
statistically no longer distinguishable on day seven of culture.
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cells in 3D printed constructs one and seven days after printing visualized by nuclear Hoechst staining
(blue) and Z-stack analysis from the top of the gel to the dish surface (scanning depth 1000 µm, interval
15.12 µm, area 1800 × 1400 µm). 3D models were recorded with the Z-stack tool, which creates a
projection of the transmitted light. Figure A shows representative images of the bioprinted 3D models
carried out as three independent experiments; (B) Qualitative viability staining of living and dead
mature HepaRG cells printed in the constructs after one and seven days of cultivation using calcein-AM
(live in green) and ethidium homodimer-1 (d ad in red). Scale bar: 200 µm; (C) Meta lic activity of
mature HepaRG cells in different 3D print d lginate/gelati /hECM bioinks was determined by the
tetrazolium hydroxide salt (XTT) assay ne and seven days after printing. Values were calcul d as
X-fold induction of lysis control; (D) Cytotoxicity was analyzed by the lactate dehydrogenase (LDH)
assay. Data are depicted as percentage of the LDH level of cells in 3D printed constructs relative to the
lysis control. For C and D, data from monolayer cultures are shown for comparison. Results are shown
as mean ± standard error of the mean (SEM) of three independent experiments. * p ≤ 0.05; ** p ≤ 0.01;
*** p ≤ 0.001; **** p ≤ 0.0001.
As an additional measure of metabolic activity, the release of lactate dehydrogenase (LDH) was
measured to determine the cytotoxicity resulting from the different bioink conditions. Figure 2D shows
that cytotoxicity of all tested bioink conditions was comparatively low (around 10% compared to
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the lysis control on day one after printing). A minor increase of about 5–10% was observed for the
cultivation period of seven days, which is also typical for conventional 2D cell culture systems as also
included in Figure 2D. Differences between day one and seven of culture were significant only for
bioinks containing 0.25 and 2 mg/mL hECM.
The reduced viability of printed HepaRG cells at a concentration of 2 mg/mL hECM came as
a surprise given the generally beneficial effects of ECM on cellular viability. The most abundant
protein in the ECM is collagen [38], which is known to modulate the mechanical properties of tissues
in vivo as well as in vitro dependent on its concentration [39,40]. One of the most common types of
the 28 known collagens in mammals is type I collagen [41]. Collagen I monomers undergo fibrillar
collagen formation at 37 ◦C and neutral pH values [42] to form hydrogels, a property which has been
used in 3D bioprinting approaches [43–46]. The majority of the studies used low concentrations of
collagen between 1 and 4 mg/mL. Likewise, most commercially available formulations contain low
concentrations of collagen. In most of these studies, only a single concentration of collagen was used,
leaving open the effects of varying concentrations on cellular behavior. Cross et al. showed that higher
collagen concentrations (>20 mg/mL) restricted cell migration and viability of human vein endothelial
cells due to the high density of the fibrillar structures [47]. This finding may explain our observation
that the hECM concentration need to be high enough to support cell viability (≥0.5 mg/mL), but must
not exceed a certain threshold of approximately 1 mg/mL to prevent detrimental effects. In addition,
the stiffness of the construct should not exceed a certain level, which must still be determined, as this
might negatively affect cell functionality.
2.2. Characterization of Hepatic Metabolism in HepaRG Cell-Laden Bioinks Containing Various Amounts of ECM
To assess the impact of different hECM concentrations on the hepatic metabolism of printed
HepaRG cells, albumin secretion and cytochrome P450 3A4 (CYP3A4) activity were analyzed.
Albumin and CYP3A4 are two of the main markers for the characterization of hepatocytes.
The production of albumin reflects the synthesis capacity of healthy cells and CYP3A4 their
biotransformation activity [48,49]. HepaRG cells plated at low densities undergo morphological
changes from an epithelial- and biliary-like phenotype to a hepatocyte-like phenotype [50,51].
The addition of dimethyl sulfoxide (DMSO) supports and maintains the hepatic maturation, which is
accompanied by increased metabolic activities like albumin expression and cytochrome P450
activity [29,30,52]. One day after bioprinting of DMSO-treated mature HepaRG cells, no substantial
differences in albumin secretion were observed between the different hECM concentrations tested
(Figure 3A). The amount of secreted albumin then rose over time under all conditions tested; however,
the increase was only statistically significant using 0.5 and 1 mg/mL hECM. At day seven of culture,
the albumin level was approximately two- to threefold higher under these conditions compared to the
other bioink compositions; the difference, again, being statistically highly significant.
CYP3A4 activity increased significantly from day one to day seven for all hECM concentrations
except the highest, 2 mg/mL (Figure 3B). The differences between the CYP3A4 activity produced
by the lower concentrations of hECM were not significant (Figure 3B). HepaRG cells cultured in
the 2 mg/mL hECM-containing bioink showed significantly lower CYP3A4 activity on day seven
compared to bioinks with other concentrations or no hECM (Figure 3B). In the absence of DMSO,
the CYP3A4 activity is substantially lower (Supplementary Figure S3). Considering both albumin
secretion and CYP3A4 activity, alginate/gelatin-based bioinks containing hECM concentrations of
0.5 or 1 mg/mL were found to be best-suited for mature HepaRG cell bioprinting. In our experiments
bioinks with 0.5 or 1 mg/mL hECM triggered the highest HepaRG albumin secretion, as well as the
highest CYP3A4 activity. In contrast, bioinks with 2 mg/mL hECM do not induce the tested hepatic
activities, which may result from negative effects of high collagen concentrations on the metabolic
conditions, as already discussed above for the LDH and XTT measurements.
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HepaRG cell-laden 3D alginate/gelatin constr it di ferent ECM concen rations on day one and
day seven; (B) CYP3A4 activity analysis of pri t ture HepaRG cells determined by CYP3A4
induced luminescence. Comparison between the different ECM concentrations on day one and day
seven. CYP3A4 luminescence was normalized to 10% Triton-X-100 treated cell lysis controls. Data from
monolayer cultures are shown for comparison. Results are shown as mean± SEM of three independent
experiments. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; **** p ≤ 0.0001.
Despite the elevated albumin secretion and CYP3A4 activity in 3D models printed with bioinks
containing 0.5 and 1 mg/mL hECM, even higher metabolic activity was measured for HepaRG cells
cultured in conventional 2D monolayers (Figure 3). A possible explanation is that the lower activity
in 3D cultures is a result of the encapsulation of the cells in the bioink, as it is essential to safeguard
the cells from pressure nd shear stress occurring during the printing process [53]. This leaves the
cells surrounded by a barrier-like layer of hydr gel, comparable to a sandwich cult re, which has
been associated with limitations in mass transport and drug sensitivity [54–56]. Consequently, it is
plausible that secreted albumin and CYP3A4-formed luciferin were not completely released from the
cells due to the surrounding hydrogel, or alternatively the diffusion of the CYP3A4 luminescence
substrate into the hydrogel was insufficient or albumin release might have been incomplete due
to interactions with the bioink material. Thus, the albumin and CYP3A4 luminescence values
measured in the 3D culture may be underestimated compared to the ones in 2D cultured HepaRG
cells, sin e a fraction of the measur d metabolic parameters might not have been fully rel ased
from the hydrogel. In additio to limitations in mass transport, the encapsulation prevents cell–cell
connection [35,44,57], which infl nces the measured metabolic activity of hepatocytes. For instance,
hepatocytes, like HepaRG cells, cultured in spheroid models show increased metabolic activity
compared to conventional monolayer culture [58,59]. Reasonable strategies to overcome this limitation
and to further improve the bioinks presented here in this study have been published, e.g., the use of
spheroids instead of single cell suspensions [60] or modified hydrogels that are sensitive to matrix
metalloproteases (MMPs) which can be used to degrade the cell encapsulation [57]. Another approach
to optimize the bioink is t e inclusion of liver-derived, instead of lung-derived hECM, as it might
contain non-collagenous proteins that may influence liver-specific metabolism.
2.3. Characterization of Rheological Properties of ECM-Based Hydrogels
The initial experiments have shown that the addition of 0.5–1 mg/mL hECM was well-suited
with respect to cell viability and metabolic activity. Furthermore, experimental handling and accurate
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maintenance of the printed structure were improved at higher hECM concentrations so that all further
experiments were carried out with bioinks containing 1 mg/mL hECM. The next step was to investigate
rheological features of the hydrogels. Elastic properties of the printed constructs were measured three
and seven days after printing using an oscillating rheometer at a frequency sweep of 0.1–10 Hz at 0.1%
shear strain. No significant changes in the elastic modulus were observed between days one and seven
of the experiment, either in the presence or in the absence of hECM (Figure 4). The printed constructs
without hECM generally showed a slightly lower elastic modulus compared to the hECM-containing
ones on both days of measurement. Taken together, the rheological analysis confirmed that the 3D
printed hydrogels with or without hECM did not lose their mechanical integrity within the time frame
of the experiments. It should be noted that the hECM used in the present study originates from a
single donor. Possible donor-to-donor variability will have to be tested in future studies.
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2.4. Transduction of Bioprinted Liver Model with Adeno-Associated Virus (AAV) Vectors
AAV vectors are efficient tools for gene delivery without inducing any recognized pathogenicity [7,61–64].
They are particularly well-suited for application in RNAi approaches [65]. Pseudotyped AAV2.6
vectors (AAV2.6) display a pronounced liver tropism [66], and so they were used in the transduction
experiments. Mature HepaRG-laden constructs cultured with or without 1 mg/mL hECM were
transduced with 1 × 105 AAV2.6/cell for seven days. Ind pendent of the concentration of hECM used,
high AAV vector transductio rates were observed, as well as even spatial d s ribution within the
printed 3D constructs seven days post-transduction. The ability of the AAV2.6 vectors to transduce
mature HepaRG cells was characterized by observing the expression of the encoded marker EmGFP,
which was analyzed by fluorescence microscopy. The overview images in Figure 5A demonstrate
widespread transduction of the cells in the printed constructs. Sections from the top, middle and
bottom of the Z-stacks are shown in the Supplementary Figure S4.
Furthermore, the functional applicability of the approach was determined by an RNAi experiment
as the vectors also expressed a small hairpin RNA (shRNA) directed against hCycB, an endogenously
expressed target that is well-suited to investigate silencing efficiency [67,68]. In the printed 3D tissue
models, transduction ith AAV2.6 mediated a average knockdown of hCycB of 70–80% compared to
the shRNA control, which was used for normalization to assess the knockdown efficiency (Figure 5B).
As no differences were observed for the bioinks containing no or 1 mg/mL hECM, we conclude that
the addition of hECM is not detrimental to the transduction efficiency of the AAV vectors. Furthermore,
the printed model and geometry including pores support widespread transduction of all cells. In a
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recent publication, we estimated by scanning electron microscopy that the pore size of an optimized
alginate/gelatin bioink supplemented with Matrigel is about 1–2 µm [35]. It is reasonable to assume
that the alginate/gelatin bioink with hECM used here has a comparable pore size. This can explain the
efficient penetration by AAV vectors we observed, since they are two orders of magnitude smaller.
This contrasts with bulky spheroids that are often too dense for large particles like viral vectors to
penetrate the 3D culture right to the center.
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vector transduction and distribution within mature HepaRG cell-laden 3D alginate/gelatin constructs,
determined by fluorescence microscopy. Comparison of constructs with and without 1 mg/mL hECM
seven days after printing. Nuclei were visualized by Hoechst staining (blue); the green fluorescence
represents green fluorescent protein (GFP) expression of AAV vectors. Scale bar: 200 µm; (B) Analysis
of shRNA-mediated hCycB RNA knockdown within the mature HepaRG cell-laden 3D alginate/gelatin
constructs, determined by reverse transcription polymerase chain reaction (RT-qPCR). Comparison
of constructs with and without 1 mg/mL hECM seven days after transduction. An shRNA control
was used for normalization to assess the knockdown. Results are shown as mean ± SEM of three
independent experiments. *** p ≤ 0.001.
2.5. Adenovirus Infection of Bioprinted Liver Model
To fur her analyz wheth r the hECM-containing 3D-printed models allow viral infection and
replication, they were infected with hAdV5 according to the scheme published in [4]. In an analogy to
testing of transduction efficiency, constructs containing no hECM or 1 mg/mL hECM were infected
with a multiplicity of infection (MOI) of 10 and incubated for three or seven days. The relative amount
of adenoviral DNA was quantified by quantitative polymerase chain reaction (qPCR) analysis of the
level of the adenoviral hexon gene and the housekeeping 18S rRNA. The adenoviral DNA amount
three days post infection with hAdv5 was used as baseline to assess the yield of viral DNA seven days
post infection. An approximately increase in the concentration of the adenoviral hexon DNA occurred
between days three and seven post-infection. The addition of hECM did not hav a statistically
significant influence, i di ating efficien replicat on of h dV5 in the 3D-printed mature HepaRG-laden
constructs (Figure 6A). Since the presence of adenoviral DNA does not directly reflect the production
of infectious viral particles, we infected A549 cells with serial dilutions of the hAdV5-containing
supernatants from the infected 3D cultures. An increase of infectious adenoviral particles was obvious
between days three and seven post-hAdV5 infection (Figure 6B). Samples taken three days post hAdV5
infection efficiently lysed A549 cell monolayers down to a dilution of 10−6. In contrast, the samples
taken seven days post-hAdV5 infection even resulted in lysed A549 monolayers down to dilutions
between 10−8 and 10−9. This result correlates nicely with the increase of adenoviral hexon DNA in
the supernatants of the hAdV5 infected 3D constructs and also indicates an increase of the number of
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infectious particles in the models, independent of the presence of hECM. The printed model is thus
suitable to study virus biology in a humanized 3D cell culture, and the addition of 1 mg/mL hECM is
not detrimental to AdV5 replication.
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3. Materials and Methods
3.1. Cell Culture and Human Extracellular Matrix Preparation
Human bipotent hepatic progenitor cells (HepaRG; Biopredic, Saint Gregoiré, France) were
cultured in William’s E medium without L-glutamine (Gibco, Dreieich, Germany) supplemented
with 10% fetal bovine serum (FBS; c.c.pro, Oberdorla, Germany), 2 mM L-Glutamine (Biowest,
Nuaillé, France), 5 µg/mL recombinant human insulin (PAN Biotech, Aidenbach, Germa y), 50 µM
hydroc rti one hemisuccinate (Sigma, Steinheim, Germany), and 1% penicillin/streptomycin (P/S;
Biowest). After 14 days, hepatic aturation was induced for additional 14 days by application of 1.7%
DMSO (Sigma) to the culture medium.
Human epithelial lung carcinoma cells (A549; ATCC, Manassas, VA, USA) were cultured using
Dulbecco´s Modified Eagle Medium (DMEM) high glucose (Biowest) supplemented with 10% fetal bovine
serum (FBS; c.c.pro), 2 mM L-Glutamine (Biowest) and 1% penicillin/streptomycin (P/S; Biowest).
Human extracellular matrix (hECM) was isolated from a lung of a deceased patient. The lung was
obtained from the German Heart Center Berlin and the study was approved by the ethics co mittee
at the Charité clinic (pr ject: EA2/079/13). For decellularization, lung pieces were subjected to 0.1%
sodium dodecyl sulfate at roo temperature for 4 h, incubated in 350 IU/mL DNase1 for tw hours
(room temperature) and sterilized in phosphate-buffered saline (PBS) supplemented with 100 U/mL
penicillin and 100 µg/mL streptomycin for 2 h. After lyophilization, hECM powder was dissolved in a
pepsin solution of 1 mg/mL (pH 2.0; prepared in 0.01 M HCl) to obtain a final hECM concentration of
10 mg/mL. The digested hECM solution was then neutralized with 10× PBS (pH 7.4) and 0.1 M NaOH
(for a detailed protocol, supplementary information). The final protein concentration was measured
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with the Pierce BCA-200 Protein Assay Kit (Thermo Fisher Scientific, Dreieich, Germany), according to
the manufacturer’s instructions, at an absorbance of A620 nm (Sunrise absorbance microplate reader,
Tecan, Männedorf, Switzerland).
3.2. Preparation of Cell-Laden Biopolymers
Gelatin (6.7% w/v) and sodium alginate (4.5% w/v) powder (Sigma) were dissolved in William’s
E medium with supplements on a magnetic stirrer at 1250 min−1, at 37 ◦C overnight. The hybrid
gelatin/alginate hydrogel was then mixed with hECM in various concentrations, mature HepaRG
cells, CaSO4 (Roth, Karlsruhe, Germany) and William’s E medium with supplements. The final
cell-laden bioink was composed of 2% w/v alginate, 3% w/v gelatin, 0; 0.25; 0.5; 1, or 2 mg/mL w/v
hECM as indicated, 0.03 M CaSO4, and 7 × 106 mature HepaRG cells/mL. Following CaSO4-driven
initial cross-linking of alginate (8 min after mixing), the cell-laden bioink was loaded into the
printing cartridge.
3.3. 3D Bioprinting
For the bioprinting process, the bioink was extruded through a 22G needle at 10–20 kPa with
the microextrusion printer INKREDIBLE+ (Cellink, Gothenburg, Sweden). The 3D construct was
designed by the computer-aided design (CAD) software Rhinoceros5 (Robert McNeel & Associates,
Barcelona, Spain). The printed constructs were submerged in 0.1 M CaCl2 (Roth) to increase gelation
of alginate and subsequently cultured in an incubator at 37 ◦C and 5% CO2 in William’s E medium
with supplements and 1.7% DMSO, as well as 0.02 M CaCl2 for up to seven days.
3.4. Rheological Properties
The viscoelastic behavior of the 3D printed constructs was analyzed using a Kinexus lab+
oscillating rheometer (Malvern, Malvern, UK) with an active hood Peltier plate cartridge (Malvern).
Before testing, samples were maintained for pre-determined time at 37 ◦C and 5% CO2 in William’s
E medium with supplements, representing the cell culture conditions. An elastic modulus of the
wet 3D printed hydrogels was recorded within a viscoelastic regime by running a frequency sweep
of 0.1–10 Hz at 0.1% shear strain. The measurements were run at 37 ◦C using an 8 mm parallel
plate geometry.
3.5. Cell Distribution
Printed cell-laden 3D constructs were fixed in 4% formaldehyde (Sigma), permeabilized with
1% Triton-X-100 (Roth) for 15 min and the nuclei were stained with 1 µg/mL Hoechst stain (H33342,
AppliChem, Darmstadt, Germany) for 1 h at room temperature. Cellular distribution was analyzed
with the Zeiss Observer. Z1 microscope (Zeiss, Jena, Germany).
3.6. Cell Viability and Lactate Dehydrogenase Release
Metabolic activity of mature HepaRG cells was determined using the XTT assay according to the
manufacturer’s instructions (AppliChem). Briefly, XTT reagent (1 mg/mL) was added on cell-laden
3D constructs and incubated for 4 h (37 ◦C, 5% CO2). The absorbance of the supernatant was measured
spectrophotometrically at A450 nm (TriStar Multimode Reader LB942, Berthold Technologies, Bad
Wildbad, Germany) with a reference of A620 nm.
Lactate dehydrogenase (LDH) release of mature HepaRG cells was measured with the LDH
detection kit (Roche, Grenzach, Germany), according to the manufacturer’s instructions, in the
supernatant at an absorbance of A492 nm with a reference of A620 nm (Sunrise absorbance microplate
reader, Tecan). XTT and LDH values were normalized to lysis controls. For cell lysis, cell-laden 3D
constructs were incubated in culture medium supplemented with 10% Triton-X-100.
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The LIVE/DEAD assay of mature HepaRG cells was performed with the Viability/Cytotoxicity
kit (Thermo Fisher Scientific), according to the manufacturer’s instructions. Briefly, cell-laden 3D
constructs were stained with 2 µM calcein-AM and 2 µM ethidium homodimer-1 diluted in 1x Hank’s
balanced salt solution (HBSS; Thermo Fisher Scientific) for 30 min (37 ◦C, 5% CO2). The stained
cell-laden 3D constructs were analyzed by fluorescence microscopy (Zeiss Observer. Z1 microscope).
3.7. Albumin Secretion and Cytochrome P450 3A4 Activity
Secreted albumin was quantified in the culture supernatant with the Human Albumin
Enzyme-Linked Immunosorbent Assay (ELISA) Kit (Bethyl laboratories, Montgomery, TX, USA),
according to the manufacturer’s instructions, at an absorbance of A450 nm (TriStar Multimode Reader
LB942) with a reference of A620 nm.
Cytochrome P450 oxidase 3A4 (CYP3A4) activity was determined with the P450-Glo CYP3A4
Assay (Promega, Mannheim, Germany), according to the manufacturer’s instructions. Briefly, CYP3A4
substrate Luciferin-PFBE (50 µM) was added on cell-laden 3D constructs and incubated at 37 ◦C,
5% CO2. After 4 h, CYP3A4-mediated conversion of Luciferin-PFBE substrate to luciferin, which is
secreted from the printed HepaRG cells, was determined. The supernatant was incubated with
Luciferin detection reagent and the luminescence was measured (TriStar Multimode Reader LB942).
Luminescence values were normalized to lysis controls. For cell lysis, cell-laden 3D constructs were
incubated in culture medium supplemented with 10% Triton-X-100.
3.8. Adeno-Associated Virus Production, Transduction, and hCycB Knockdown
Pseudotyped scAAV vectors of serotype 6 (AAV2.6) encoding an expression cassette for an shRNA
against hCycB and Emerald green fluorescent protein (EmGFP), were produced, purified and titrated
as previously described [69]. HepaRG-laden 3D constructs were transduced with 1 × 105 AAV/cell
in William’s E medium with supplements without DMSO. To determine transduction efficiency,
EmGFP-expression in transduced HepaRG cells was analyzed by fluorescence microscopy (Zeiss
Observer. Z1 microscope) seven days after transduction. To quantify hCycB knockdown, RNA for
RT-qPCR experiments (see below) was isolated with the NucleoSpin TriPrep (MACHEREY NAGEL,
Düren, Germany) according to manufacturer’s instructions.
3.9. Human Adenovirus 5 Preparation and Infection
Human adenovirus 5 (hAdV5), obtained from Stefan Weger (Institute of Virology, Campus
Benjamin Franklin, Charité-Universitätsmedizin, Berlin, Germany), was grown on HEK293 cells.
Viral titers were determined by standard plaque assay on HEK293 cells [4]. For adenoviral infection,
cell-laden 3D printed constructs were washed three times with 1× HBSS and inoculated with hAdV5
(MOI of 10) for 30 min at room temperature. Afterwards, William’s E medium without L-glutamine
supplemented with 2% FBS, 2 mM L-Glutamine, 5 µg/mL recombinant human insulin, 50 µM
hydrocortisone hemisuccinate, and 1% P/S without DMSO was added, and the cell-laden 3D constructs
were incubated at 37 ◦C and 5% CO2. Twenty-four hours after the printing procedure, the 3D tissues
were infected with AdV5. Three and seven days post infection, the adenovirus-containing supernatants
were collected for adenoviral replication analysis by qPCR experiments (see below).
3.10. Cell-Killing Assay
Cell-laden 3D constructs were infected and incubated as described above. On days 3
and 7 after infection, the adenovirus-enriched supernatant was collected, diluted (10−1–10−12)
in DMEM high glucose supplemented with 2% FBS, 1% 100× L-Glutamine, 1% P/S, and
transferred on A549 cells. After reinfection overnight, the cells were covered with 5%
low melting point agar (Sigma) in DMEM high glucose supplemented with 5% FBS, 1%
100× L-Glutamine, 1% P/S and incubated for 24 h (37 ◦C; 5% CO2). After seven days,
the covered cells were stained with 2 × 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
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(MTT)-2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride (VWR-Chemicals, Dresden,
Germany) for 2 h (37 ◦C; 5% CO2) to determine the viral effect.
3.11. Reverse Transcription and Quantitative Polymerase Chain Reaction (qPCR)
The expression of hCycB was quantified by RT-qPCR as described previously [69]. Briefly, equal
amounts of RNA were subjected to reverse transcription (RT) using the RevertAid H Minus First
Strand cDNA Synthesis Kit and random hexamer primers (MBI Fermentas, St. Leon-Rot, Germany)
according to the manufacturer’s instructions.
For qPCR of hCycB and 18S rRNA cDNAs and adenoviral hexon DNA, the SsoFastEvaGreen
Supermix (BioRad, München, Germany) was used. Reaction mixtures, thermocycling programs and
primer sequences are described in Supplementary Tables S1–S3. The relative hCycB RNA expression
was normalized to 18S rRNA and determined by the ∆∆Ct method. Adenoviral hexon DNA was
evaluated by the ∆Ct method.
3.12. Statistical Analysis
Statistical evaluation of experiments was performed using two-way analysis of variance (ANOVA)
with Bonferroni correction (GraphPad Prism 6, GraphPad Software, Inc.; La Jolla, CA, USA). Each
set of cell-laden experiments was repeated in minimum of three times. Data are represented as
mean ± standard error of the mean (SEM), p values are considered significant by * p ≤ 0.05; ** p ≤ 0.01;
*** p ≤ 0.001, **** p ≤ 0,0001.
4. Conclusions
Taken together, our findings demonstrate that supplementation of an alginate/gelatin bioink
with 0.5–1 mg/mL hECM improves cell viability and hepatic metabolic activity (Figures 2C and
3) in a humanized 3D liver model generated by extrusion bioprinting. The bioink provides high
precision in the printing process and stability of the printed constructs during prolonged cultivation.
Supplementary Figure S5 shows some additional 3D shapes that were printable with the bioink.
The hECM was not detrimental to transduction of the tissue model by AAV vectors or its infection
with human adenovirus 5. It improved the properties of the bioink for the bioprinting process and for
the accurate maintenance of a defined 3D structure. ECM from human donors can thus be used to
replace supporting protein mixtures such as Matrigel™ that are widely used, but have to be harvested
from mouse tumors. The use of human ECM thus reduces the number of animals needed to obtain the
supporting material for bioinks and avoids problems that may arise from species-specific differences
between mouse and human. In addition, the hECM used is not of tumorous origin and provides a
normal environment for the cells. Future studies should look into the possibility that liver-derived
hECM behaves differently than lung-derived and attempt to replace the components of non-human
origin in the bioink by materials found in the human organism. In addition, cellular interaction
with the matrix may be further improved by the addition of proteinaceous components such as RGD
(Arg-Gly-Asp) motifs. The design of the tissue model printed here allowed widespread transduction
of the cells in the construct, which is not possible in large spheroids which tend to be too dense for
penetration by large particles such as viruses and viral vectors to the center. Therefore, we conclude
that extrusion-based bioprinting of 3D tissue models with a bioink containing human ECM is a suitable
approach to generate models for transduction and transfection studies.
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